This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

News Articles: Researchrss feed

PROJECT USING SMART DEVICES TO DETECT HEART PROBLEMS GETS FUNDING FROM NATIONAL CHARITY

A project to test how effective smart devices are at detecting heart rhythm problems has received a grant of almost £150,000 from national charity Heart Research UK.  The project, which will recruit 50 patients at Oxford University Hospitals (OUH) NHS Foundation Trust, will assess whether smart rings and watches can offer an accurate and reliable way […]

Risk of rare blood clotting higher for COVID-19 than for vaccines

COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines. Researchers at the University of Oxford have today reported that the risk of the rare blood clotting known as cerebral venous thrombosis (CVT) following COVID-19 infection is around 100 times greater than normal, several times higher than […]

T-CELL LANDSCAPE MAPPING IDENTIFIES NEW TARGETS FOR PANCREATIC CANCER IMMUNOTHERAPY

Oxford researchers have used analysis of T-cell populations to identify new therapeutic opportunities in pancreatic cancer patients.  Pancreatic cancer has one of the worst prognoses of any cancer, with pancreatic ductal adenocarcinoma (PDAC) patients having an average survival rate of 7%.  T-cells (the lymphocytes that play a wide range of roles in shaping the body’s immune response […]

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants. Early treatment with inhaled budesonide shortens recovery time by a median of three days in […]

Link between COVID-19 infection and subsequent mental health and neurological conditions found

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders. Professor Paul Harrison, lead author of the study, […]

New national study of long-term impacts of debilitating lung damage from COVID-19

A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability. Many people recovering from COVID-19 suffer from long-term symptoms of lung damage, including breathlessness, coughing, fatigue and […]

Oxford Brookes ranked highly for commercialisation and research partnerships

Oxford Brookes University’s successful work in commercialising its intellectual property (IP), predominantly through IP licensing but also through spinouts, has been ranked in the top 10% of English universities in the first Knowledge Exchange Framework results published today [Wednesday 31 March] by Research England. Oxford Brookes was placed in the top 40% for its research […]

Opportunities for final goodbyes must be prioritised in COVID-19 pandemic

Bereaved relatives described the ongoing pain of being absent at the end of a loved-one’s life. Many had not seen their relative for weeks or months due to the pandemic. Opportunities must be prioritised for essential connections between families at end-of-life care. The first paper to give voice to those bereaved during the pandemic is […]

NEW ROLES FOR OXFORD AHSN CHIEF OFFICER AND OUH CONSULTANT

Professor Gary Ford, Chief Executive of the Oxford Academic Health Science Network and consultant stroke physician at OUH, is the new Chair of the AHSN Network, the national body bringing together England’s 15 AHSNs. Gary said: “I am delighted to be taking on this role at an important time for AHSNs and the wider NHS. […]